Companies / Amber Bio
Amber Bio
United States
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.
Amber Bio, based in United States, has 4 investors on file, among them Andreessen Horowitz, Hummingbird and Pillar. Its latest round on record is Seed, 3 Aug 2023. Its site was last checked 12 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Page + round | Venture capital | |
| Page + round | Venture capital | |
| Page + round | Venture capital | |
| Page + round | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Amber Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Andreessen Horowitz adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/amber.bio/investors
# also
GET /v1/companies/amber.bio
GET /v1/companies/amber.bio/news